Trial in Progress: A Phase 3 Randomized Study of Low-Dose Intralesional Cemiplimab Versus Primary Surgery for Patients With Early-Stage Cutaneous Squamous Cell Carcinoma (CLEAR CSCC). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s689, 2025. DOI: 10.25251/cpgrax68. Disponível em: https://skin.dermsquared.com/skin/article/view/3845. Acesso em: 30 apr. 2026.